Intensity Therapeutics Inc (INTS) concluded trading on Wednesday at a closing price of $0.32, with 4.23 million shares of worth about $1.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -84.51% during that period and on June 18, 2025 the price saw a gain of about 11.58%. Currently the company’s common shares owned by public are about 15.26M shares, out of which, 10.02M shares are available for trading.
Stock saw a price change of -44.91% in past 5 days and over the past one month there was a price change of -20.47%. Year-to-date (YTD), INTS shares are showing a performance of -81.87% which decreased to -93.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.28 but also hit the highest price of $5.10 during that period. The average intraday trading volume for Intensity Therapeutics Inc shares is 958.88K. The stock is currently trading -21.75% below its 20-day simple moving average (SMA20), while that difference is down -59.12% for SMA50 and it goes to -85.92% lower than SMA200.
Intensity Therapeutics Inc (NASDAQ: INTS) currently have 15.26M outstanding shares and institutions hold larger chunk of about 14.07% of that.
The stock has a current market capitalization of $5.87M and its 3Y-monthly beta is at 4.34. It has posted earnings per share of -$1.06 in the same period. It has Quick Ratio of 0.63 while making debt-to-equity ratio of 0.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INTS, volatility over the week remained 7.72% while standing at 17.52% over the month.
Stock’s fiscal year EPS is expected to rise by 43.38% while it is estimated to increase by 18.99% in next year. EPS is likely to grow at an annualized rate of 17.65% for next 5-years, compared to annual growth of -23.29% made by the stock over the past 5-years.
